Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Vsee Health (VSEE) Gains from Investment Securities (2023 - 2024)

Vsee Health filings provide 2 years of Gains from Investment Securities readings, the most recent being -$363982.0 for Q4 2024.

On a quarterly basis, Gains from Investment Securities fell 206.98% to -$363982.0 in Q4 2024 year-over-year; TTM through Sep 2025 was -$363982.0, a 234.07% decrease, with the full-year FY2025 number at $25000.0, changed N/A from a year prior.
Gains from Investment Securities hit -$363982.0 in Q4 2024 for Vsee Health, down from $361210.0 in the prior quarter.
In the past five years, Gains from Investment Securities ranged from a high of $1.2 million in Q1 2023 to a low of -$363982.0 in Q4 2024.